Role of Pioglitazone in Preventing Diabetes
Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Listed as NCT00276497, this PHASE1 trial focuses on Diabetes and remains completed. Sponsored by India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Oct 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
- M.V. Hospital for Diabetes
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.